Synopsis: Citius Transnet Investment Trust plans a Rs. 1,105 crore IPO to fund road asset acquisitions. It offers stable cash flows from a diversified portfolio, but ongoing losses and negative net worth highlight its long-term investment-focused strategy. The company...
Synopsis:- A ₹244.65 crore issue priced at ₹10–10.5 lakh per unit targets HNIs and institutions, with 75% reserved for QIBs. Backed by a 2.07 lakh sq. ft. Grade A+ asset and 10 tenants, GMP signals 0% listing premium and neutral sentiment. Propshare Celestia IPO is a...
Synopsis:- The Rs 150.06 crore IPO, priced at Rs 166–Rs 175, shows a balanced mix of fresh issue and OFS, with a Rs 744.60 crore order book supporting visibility. With GMP at Rs 176.5 and ROE at 24.28%, the company reflects steady growth potential despite promoter...
Synopsis: INOX Air Products’ planned $1 billion IPO aims to fund expansion, strengthen supply chains, and capture rising demand amid global gas supply concerns. The proceeds will support capacity growth, logistics, and entry into new sectors, positioning the company...
Synopsis: Ten major companies, including Pride Hotels, Hero Motors, and Milky Mist Dairy, have received SEBI approval for IPOs, raising capital for debt repayment, expansion, marketing, and strategic investments across sectors like hospitality, energy, finance, and...
Synopsis:- The ₹1,100 crore IPO includes ₹700 crore fresh issue and ₹400 crore OFS, with a price band of ₹375–₹395. Despite 0% GMP indicating muted listing expectations, focus remains on ₹525 crore debt reduction, 279.55 MW renewable capacity, and moderate valuation...
SYNOPSIS: Amir Chand Jagdish Kumar (Exports) Limited is launching a ₹440 crore IPO (fresh issue of 2.08 crore shares) to fund working capital and corporate needs. The issue opens on March 24, 2026, offering investors exposure to India’s basmati rice processing and...
Synopsis: Sai Parenterals’ mainboard IPO brings a diversified pharma formulations and CDMO player to the primary market. The company plans to use the issue proceeds for capacity expansion, a new R&D centre, debt repayment, working capital, and overseas investment,...
Synopsis:- IPO worth ₹400 crore with price band ₹304–₹320, lot size 46 shares. GMP suggests flat listing. Funds mainly for ₹170 crore debt reduction. Strong R&D base with 524 registrations, presence across 20 states and 37 countries, but faces regulatory and raw...
